Gynecological Malignancies Managed in The Institute of Nuclear Medicine and Oncology, Wadmedani-Sudan During 1999-2005
Abstract
Introduction: Gynecological malignancies (GMs) are one of the most prevalent cancers in Africa. Objective of this work is to review data of patients with GMs treated in Institute of Nuclear Medicine, Molecular Biology and Oncology (INMO)-University of Gezira -Wadmedani- Sudan, and reflect on characteristics of GMs in Central Sudan.
Material and Methods: A retrospective hospital-based descriptive study was conducted to review GMs patients records treated in INMO from year 1999-2005. Analysis included age, residence, stage, topography and morphology of the cancer.
Results: During study period GMs constituted about 20.5 percent of all women malignancies and it is the second commonest female cancer preceded by breast (36.7%). Most of the patients were housewives from rural areas of Gezira and nearby States. The sites were ovary, 41%, cervix, 34%, uterus, 13.8%, uterine choriocarcinoma, 7.9%, vulva cancer, 2.9% and no single case of vaginal carcinoma was reported. The mean age of all patients was 52.45 years, Median age for ovarian cancer was, 50, cervix 55, uterus 55, Choriocarcinoma of the uterus 35 and vulva 60 years of age.
Almost all varieties of histopathological types were seen. Fifty eight percent of patients presented with stage III & IV.
Conclusions: GMs are common and present in late stages. The commonest GMs was ovarian cancer which affect relatively young patients. Cervix was the second common site and affect relatively older age group. Vulvar cancer was relatively rare and vaginal cancer was not seen. For the improvement of the outcome early detection, management guidelines and financial support are highly recommended.
References
2. D.M. Parkins, S.L. Whelan, J.Ferlay, L.Teppo and D.B. Thomas,IACR scientific publications N0.155,France,Cancer incidence in five continents,93-514.
3. Wharton JT, Neoplasms of cervix. In Holland JF, Bast RC, Jr, Norton DL, Feri E, III, Kufe DW(eds) cancer medicine, 4th edition. Baltimore: Williams & Wilkins, 1997: 22-27.
4. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics 1996, Vol. 65. CA, 1996: 5-27.
5. Mauad EC, Gomez UA, Nougeria AL, Melani AGF, Lemos DL, Hidalgo GS. Prevention of cervical cancer in a poor population in Brazil. Family practice 2002; 19:189-192.
6. Ferlay J, Bray F, Pisani P, Parkin D. Globocan 2002. Cancer incidence, mortality and prevalence worldwide. IARC. Cancer base NO.5, version 2:2004.
7. Parkin DM, Bray F, Ferlay J, Pisani P.Global cancer statistic 2002. CA: A Cancer journal for clinician. 2005a; 55(2): 74-108.
8. H. M. A. Hamad. Cancer initiative in Sudan. Annals of oncology; 2006; 17: supplement 8(viii32-36).
9. Chukwuali, L. I., Onuigbo, W. I. B., Mgbor, N. C. Cervical cancer screening in Enugu, Nigeria. Tropical Journal of Obstetrics and Gynecology; 2003; 20: 109-112 (abstract).
10. R. J. Ednomonson, J. M. Monaghan.The epidemiology of ovarian cancer. Int J Gynecol cancer; 2001; 11: 423-29.
11. Gustafsson L. Pontén J, Bergström R, Adami HO. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997; 71: 159–165.[Medline]
12. Sun L, Zhan Q, Zhang W, Song Y, Tong T. Aberrant expression of Notch 1 in cervical cancer. Chinese journal of clinical oncology; 2007; 4: 63-41.
13. Sadjadi A, Malekzadeh R, Drakhshan MH,et al. Cancer occurrence in Ardabil results of a population-based cancer registry from Iran. Int J Cancer; 2003; 107: 113-118.
14. Yu CK, Chiu C, McCormack M, Olaitan A. Delayed diagnosis of cervical cancer in young women. Journal of obstetrics and gynecology; 2005; 25: 367-70.
15. Singh N. HPV and cervical cancer- prospects for prevention through vaccination. Indian journal of medical & pediatric oncology; 2005; 26: 20-23.
16. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J clin pathol; 2002; 55: 244-265.
17. Munoz N, Bosch FX, de Sanjose S. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518–527.
18. Peter G. Rose. Endometrial Carcinoma. N Eng J Med; 1996; 335:640-649.
19. Balagopal PG, Pandey M, Chandramohan K, Somanathan T, Kumar A. Unusual presentation of Choriocarcinoma. World journal of surgical oncology; 2003; 1: 4.
20. Rosen C, Malmstrom H. Invasive cancer of Vulva. Gynecologic oncology; 1997; 65: 213-217.( abstract).